Pill effects on breast, ovarian CA same in high-risk women

Pill effects on breast, ovarian CA same in high-risk women

(HealthDay)—Among women who are BRCA1/2 mutation carriers, the associations between ever use of oral contraceptives (OCs) and ovarian and breast cancers are similar to those observed in the general population, according to research published online Oct. 21 in the Journal of Clinical Oncology.

Patricia G. Moorman, Ph.D., of Duke University in Durham, N.C., and colleagues performed a systematic review of the literature and meta-analysis to estimate the risks of breast cancer and ovarian cancer associated with use of OCs in women at increased risk.

The researchers note that meta-analysis showed a significant inverse association between OC use and (odds ratio [OR], 0.58; 95 percent confidence interval [CI], 0.46 to 0.73) and a non-significant association between OC use and breast cancer (OR, 1.21; 95 percent CI, 0.93 to 1.58) for BRCA1 and BRCA2 mutation carriers combined. Similar patterns were observed when mutation carriers were analyzed separately.

"Our analyses suggest that associations between ever use of OCs and ovarian and among women who are BRCA1 or BRCA2 mutation carriers are similar to those reported for the ," the authors write.


Explore further

BRCA2 mutations associated with improved survival for ovarian cancer

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Journal of Clinical Oncology

Copyright © 2013 HealthDay. All rights reserved.

Citation: Pill effects on breast, ovarian CA same in high-risk women (2013, October 22) retrieved 8 December 2019 from https://medicalxpress.com/news/2013-10-pill-effects-breast-ovarian-ca.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments